At a $323M market cap, TCPC screens optically cheap with a 6.1 Forward P/E and a 0.5 Price/Book, but this is not a clean value story. The absence of current EPS, negative Return on Equity of -9.20%, Operating Margin of -14.90%, and ROIC of -1.80% signal a business currently destroying capital. The Piotroski F-Score of 3 confirms weak financial quality, and with EPS Next Year estimated at -$1.05, the low forward multiple reflects skepticism, not hidden growth. This is statistically “cheap,” but financially impaired, and the market appears to be discounting real deterioration rather than mispricing a healthy compounder.